Drug Shortage Report for BUSCOPAN
Report ID | 173153 |
Drug Identification Number | 00363839 |
Brand name | BUSCOPAN |
Common or Proper name | BUSCOPAN AMP. |
Company Name | SANOFI CONSUMER HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | HYOSCINE BUTYLBROMIDE |
Strength(s) | 20MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10 |
ATC code | A03BB |
ATC description | BELLADONNAAND DERIVATIVES, PLAIN |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-09-23 |
Estimated end date | |
Actual end date | 2022-11-21 |
Shortage status | Resolved |
Updated date | 2022-11-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2905 PLACE LOUIS-R RENAUD LAVAL, QUEBEC CANADA H7V 0A3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-11-22 | English | Compare |
v7 | 2022-11-09 | French | Compare |
v6 | 2022-11-09 | English | Compare |
v5 | 2022-11-09 | English | Compare |
v4 | 2022-10-31 | French | Compare |
v3 | 2022-10-31 | English | Compare |
v2 | 2022-10-31 | French | Compare |
v1 | 2022-10-31 | English | Compare |
Showing 1 to 8 of 8